First-in-man histotripsy of hepatic tumors: the THERESA trial, a feasibility study

Author:

Vidal-Jove Joan1,Serres Xavier2,Vlaisavljevich Eli3,Cannata Jon4,Duryea Alex4,Miller Ryan4,Merino Xavier2,Velat Manuela1,Kam Yossi5,Bolduan Ryan6,Amaral Joseph6,Hall Timothy7,Xu Zhen7,Lee Fred T.8,Ziemlewicz Timothy J.8

Affiliation:

1. Institute Khuab for Interventional Oncology, Comprehensive Tumor Center, Barcelona, Spain

2. Department of Interventional Ultrasound, Vall d’Hebron University Hospital, Barcelona, Spain

3. Department of Biomedical Engineering, Virginia Polytechnic University, Blacksburg, Virginia

4. Research and Development, Histosonics, Inc, Ann Arbor, MI, USA

5. R&D Clinical Excellence, Philips Healthcare, Haifa, Israel

6. Clinical Research and Medical Affairs, Histosonics, Inc, Ann Arbor, MI, USA

7. Department of Biomedical Engineering, University of Michigan, Ann Arbor, MI, USA

8. Department of Radiology, University of Wisconsin, Madison, WI, USA

Funder

Histosonics, Inc

Publisher

Informa UK Limited

Subject

Cancer Research,Physiology (medical),Physiology

Cited by 58 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3